DPC2018 exhibitor Diabetes Knowledge in Practice to run free interactive webinar on ultra-fast insulins
Just over a month ahead of DPC2018, on October 9 at 13:00 BST, Professor David Matthews and Dr John Buse will host an interactive discussion on the recent Onset 8 study.
Run by DPC2018 exhibitor Diabetes Knowledge in Practice and entitled ‘Combination approaches with ultra-fast insulin: Observations from Onset 8’, this webinar will be an unmissable opportunity to discuss novel data with these international experts and find out what implications these data have for your patients.
Ultra-fast insulins are a new formulation of prandial insulin, designed to be absorbed much faster than current-generation formulations. In doing so, these ultra-fast insulins start working faster, provide increased insulin exposure within the first half-hour and a shorter post-dose ‘tail’ as compared to current prandial insulins.
The first of these ultra-fast insulins, faster insulin aspart, has been approved by the European Medicines Agency. A number of trials have evaluated the safety and efficacy of faster aspart compared to insulin aspart, the latest of which being Onset 8. This study looked specifically at patients receiving insulin degludec, an ultra-long basal insulin, and evaluated the difference between ultra-fast and conventional fast-acting prandial insulins over 26 weeks of treatment.
The results are now available online, and set to be published as a paper within the next month. These interesting results indicate new opportunities for patients with type 1 diabetes to have more control over post-prandial glucose, including post-meal dosing.
So what does this mean for your patients? In the wider context of the onset trials, what can we conclude about ultra-fast insulins? Who will benefit, and when should they be used?
To find out, join the webinar on October 9. Registration is free and takes under 30 seconds.
If you regularly see patients with type 1 diabetes, don’t miss this exciting opportunity to have your questions answered by Professor David Matthews and Dr John Buse, both international experts in this area.
This interactive session will be run by Diabetes Knowledge in Practice. This educational programme features a range of free, CME-accredited e-learning modules designed by leading experts in diabetes management. Topics include navigating insulin choices, managing diabetes in pregnancy, effective use of GLP-1 receptor agonists and helping patients address post-prandial glucose concentrations.
Diabetes Knowledge in Practice is supported by an educational grant from Novo Nordisk. The educational content has been developed by Liberum IME and validated by an independent steering committee; Novo Nordisk has had no influence on the content of this education.
Come along to stand D26 at DPC2018 to meet Diabetes Knowledge in Practice, whose team of experts will be on hand to answer your questions about ultra-fast insulins and its range of free, online educational content for HCPs involved in diabetes care.